MMP2 and cancer: Collectively, these findings reveal cell-type-specific modulation of oncogenic and suppressor pathways.<h4>Conclusion</h4>This multi-cancer investigation identifies ENOX2-MMP2 signaling as a functional driver of invasion and metastasis and demonstrates that mebendazole reprograms oncogenic-tumor suppressor networks.